FNY Investment Advisers, LLC Q1 2023 vs. Q2 2023 13F Holdings Comparison

FNY Investment Advisers, LLC has recently released its 13F holdings report for the first and second quarters of 2023. This report showcases the changes in holdings for various companies during this period. In this article, we will dive into the details of these changes and what they might mean for investors.

IVERIC BIO ORD - Significant Increase in Holdings

One notable change in FNY Investment Advisers, LLC's holdings is the significant increase in shares of IVERIC BIO. In Q1 2023, FNY Investment Advisers, LLC held zero shares of IVERIC BIO. However, in Q2 2023, their holdings drastically increased to 180,106 shares. This change represents a substantial jump and indicates a growing interest in the company.

HORIZON THERAPEUTICS PUBLIC ORD - Decrease in Holdings

On the other hand, FNY Investment Advisers, LLC reduced its holdings in HORIZON THERAPEUTICS PUBLIC. In Q1 2023, they held 58,872 shares of the company, but in Q2 2023, the holdings dropped to 44,395 shares. This decrease in holdings might suggest a change in strategy or a shift in focus towards different investment opportunities.

BYRNA TECHNOLOGIES ORD - Decline in Holdings

FNY Investment Advisers, LLC also experienced a decline in holdings for BYRNA TECHNOLOGIES. In Q1 2023, they held 773,052 shares of the company, but in Q2 2023, the holdings decreased to 752,600 shares. This slight decline could be attributed to various factors, including market conditions, company performance, or portfolio adjustments.

LABORATORY CORPRTN OF AMER HLDGS ORD - New Holdings

In an interesting turn, FNY Investment Advisers, LLC introduced a new position in LABORATORY CORPRTN OF AMER HLDGS. They did not hold any shares of the company in Q1 2023, but in Q2 2023, they acquired 12,825 shares. This new investment indicates a potential positive outlook for the company and highlights FNY Investment Advisers, LLC's confidence in its growth prospects.

COCA-COLA ORD - Increase in Holdings

FNY Investment Advisers, LLC also increased its holdings in COCA-COLA during this period. In Q1 2023, they held 31,000 shares, but in Q2 2023, the holdings grew to 42,500 shares. This increase in holdings signals confidence in the company's performance and long-term prospects.

SEAGEN ORD - Substantial Growth in Holdings

Another company that saw a significant increase in holdings by FNY Investment Advisers, LLC is SEAGEN. In Q1 2023, they held 4,420 shares, but in Q2 2023, the holdings skyrocketed to 11,934 shares. This substantial growth in holdings demonstrates FNY Investment Advisers, LLC's strong belief in SEAGEN's potential and their commitment to capturing its growth.

BORGWARNER ORD - New Holdings

FNY Investment Advisers, LLC also initiated a new position in BORGWARNER during Q2 2023. They did not hold any shares of the company in Q1 2023, but in Q2 2023, they acquired 51,700 shares. This new addition to their portfolio suggests a positive outlook for BORGWARNER and reflects FNY Investment Advisers, LLC's strategic investment decisions.

Conclusion

FNY Investment Advisers, LLC's 13F holdings report for Q1 2023 vs. Q2 2023 provides valuable insights into their investment decisions and portfolio adjustments. The significant changes in holdings for various companies indicate an active approach to portfolio management and a focus on potential growth opportunities. Investors can gain inspiration from these changes and consider researching these companies for their own investment strategies.